Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $46,191 - $51,395
-221 Reduced 1.69%
12,844 $2.81 Billion
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $386,879 - $444,806
-1,957 Reduced 13.03%
13,065 $2.97 Billion
Q3 2023

Nov 15, 2023

SELL
$201.05 - $221.7 $280,866 - $309,714
-1,397 Reduced 8.51%
15,022 $3.02 Billion
Q2 2023

Aug 15, 2023

SELL
$211.93 - $241.33 $7,841 - $8,929
-37 Reduced 0.22%
16,419 $3.96 Billion
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $254,064 - $307,075
1,191 Added 7.8%
16,456 $3.78 Billion
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $86,581 - $105,812
-425 Reduced 2.71%
15,265 $3.59 Billion
Q3 2022

Nov 07, 2022

SELL
$204.81 - $262.19 $406,138 - $519,922
-1,983 Reduced 11.22%
15,690 $3.21 Million
Q2 2022

Aug 09, 2022

SELL
$213.86 - $277.87 $564,590 - $733,576
-2,640 Reduced 13.0%
17,673 $4.14 Million
Q1 2022

May 06, 2022

BUY
$259.82 - $298.18 $1,299 - $1,490
5 Added 0.02%
20,313 $5.36 Million
Q4 2021

Feb 09, 2022

SELL
$271.6 - $314.21 $668,679 - $773,585
-2,462 Reduced 10.81%
20,308 $6.38 Million
Q3 2021

Nov 08, 2021

SELL
$274.82 - $308.34 $1.5 Million - $1.69 Million
-5,476 Reduced 19.39%
22,770 $6.41 Million
Q2 2021

Aug 02, 2021

SELL
$251.87 - $278.14 $344,810 - $380,773
-1,369 Reduced 4.62%
28,246 $7.79 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $13,931 - $17,342
68 Added 0.23%
29,615 $7.55 Million
Q3 2020

Nov 18, 2020

SELL
$167.03 - $201.3 $16,703 - $20,130
-100 Reduced 0.34%
29,547 $5.56 Million
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $4,532 - $7,297
-40 Reduced 0.13%
29,647 $4.93 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $40,997 - $76,745
-393 Reduced 1.31%
29,687 $3.75 Million
Q4 2019

Feb 12, 2020

SELL
$163.48 - $173.61 $67,844 - $72,048
-415 Reduced 1.36%
30,080 $5.09 Million
Q3 2019

Nov 13, 2019

SELL
$159.77 - $178.1 $267,614 - $298,317
-1,675 Reduced 5.21%
30,495 $5.12 Million
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $746,028 - $894,757
-5,175 Reduced 13.86%
32,170 $5.56 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $88,074 - $111,285
-712 Reduced 1.87%
37,345 $5.71 Million
Q4 2018

Feb 11, 2019

SELL
$120.82 - $174.09 $33,829 - $48,745
-280 Reduced 0.73%
38,057 $4.81 Million
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $884,291 - $992,935
-5,274 Reduced 12.09%
38,337 $6.66 Million
Q2 2018

Aug 16, 2018

SELL
$160.33 - $189.41 $562,758 - $664,829
-3,510 Reduced 7.45%
43,611 $7.83 Million
Q1 2018

May 09, 2018

SELL
$161.53 - $178.11 $1.23 Million - $1.36 Million
-7,623 Reduced 13.92%
47,121 $7.62 Million
Q4 2017

Feb 22, 2018

BUY
$147.99 - $163.95 $611,198 - $677,113
4,130 Added 8.16%
54,744 $8.73 Million
Q3 2017

Nov 14, 2017

SELL
$149.47 - $160.56 $14,947 - $16,056
-100 Reduced 0.2%
50,614 $7.64 Million
Q2 2017

Aug 15, 2017

BUY
N/A
50,714
50,714 $7.82 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Fairfield, Bush & Co. Portfolio

Follow Fairfield, Bush & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.